Machine Learning Reads Speech to Detect Cognitive Impairment in Schizophrenia

When people speak, they reveal far more than the content of their words. The richness of their vocabulary, the complexity of their sentences, the way ideas connect from one clause to the next, and even the emotional coloring of their language all carry measurable signatures of how the brain is organizing thought. A new study published in the journal Schizophrenia has now shown that these signatures, extracted automatically from ordinary speech, can distinguish schizophrenia patients whose cognition has been eroded from those whose thinking remains largely intact. The work, led by Seoung-Ho Choi of Hansung University and Ling Li of Jeonbuk National University Medical School, together with colleagues in South Korea, is notable not only for its clinical findings but also for its language: the researchers analyzed Korean speech, extending a field that has been dominated by English-language data.

Schizophrenia has long been associated with disturbances of language and thought. Clinicians describe formal thought disorder, a pattern of disorganized or incoherent speech that can range from tangential rambling to outright derailment. Decades of research have linked this phenomenon to the cognitive deficits that many patients experience, including impairments in memory, attention, and executive function. What has been missing, the authors argue, is a systematic account of which specific, automatically extractable linguistic features track cognitive status in schizophrenia. Traditional clinical assessment of thought disorder is subjective, time-consuming, and dependent on the judgment of trained raters. Computational methods promise something different: objective, reproducible measurements that could one day support screening and monitoring in routine care.

To pursue that goal, the team assembled speech samples from 88 patients with schizophrenia and 69 healthy controls. Among the patients, 37 were classified as cognitively impaired and 51 as cognitively preserved, a distinction based on their cognitive test performance. This split is the heart of the study’s design. Rather than simply asking whether the speech of patients differs from that of healthy people, the researchers asked whether the speech of cognitively impaired patients differs from that of cognitively preserved patients, a far more demanding comparison that speaks directly to the question of whether language can serve as a window onto cognition in the illness.

The technical machinery behind the analysis was a set of natural language processing pipelines adapted specifically for Korean. Korean poses distinctive challenges for computational linguistics. It is an agglutinative language in which particles and endings attach to stems, word boundaries are less transparent than in English, and the order of elements within a sentence is relatively free. Standard NLP tools built for English cannot simply be repurposed. The researchers therefore adapted their pipelines to handle Korean morphology and syntax, and from the transcribed speech they extracted features across four broad categories: lexical, syntactic, semantic, and sentiment.

Each of these categories captures a different dimension of language production. Lexical features measure the richness and diversity of vocabulary, including how many different words a speaker uses relative to the total number of words produced. Syntactic features quantify the structural complexity of sentences, such as the depth of embedding and the length and elaboration of clauses. Semantic features assess coherence, the degree to which successive utterances stay on topic and connect meaningfully to one another, which is precisely the quality that deteriorates in formal thought disorder. Sentiment features capture the emotional polarity of the language, tracking whether speech is expressed in positive or negative terms. Together, these measures form a multidimensional profile of each speaker’s verbal output.

The results were striking. Patients with cognitive impairment showed marked reductions across all four domains compared with both cognitively preserved patients and healthy controls. Their vocabulary was poorer, their sentences structurally simpler, their discourse less semantically coherent, and their emotional expressiveness flatter. The cognitively preserved patients, by contrast, fell between the two extremes, showing some linguistic disturbances relative to controls but considerably less pronounced than those seen in the impaired group. This graded pattern is important because it suggests that linguistic measures are not merely detecting the presence of schizophrenia but are sensitive to the degree of cognitive compromise within the disorder, which is exactly what a useful cognitive marker would do.

The researchers also took care to control for a potential confound that plagues speech studies in psychiatry: medication. Antipsychotic drugs can produce motor side effects, and the severity of such extrapyramidal symptoms could plausibly influence speech production independently of cognition. By using the Extrapyramidal Symptom Rating Scale to account for these effects, the team strengthened the argument that the linguistic differences they observed reflect cognitive and linguistic processes rather than the pharmacological treatment itself. Several of the linguistic features also correlated with the severity of patients’ symptoms and with their performance on language tasks, providing convergent evidence that the computational measures were capturing clinically meaningful variation.

The machine learning component of the study was framed as an exploratory analysis, and its results carry an instructive lesson about the state of the field. The researchers trained classifiers to distinguish the patient groups from one another and from controls, and they observed a discrepancy between the mean performance estimated across the outer folds of cross-validation and the performance achieved on a held-out test dataset. In practical terms, the models did not generalize as well as the cross-validation estimates suggested. This kind of gap is a well-known hazard in studies with modest sample sizes, where models can inadvertently capitalize on idiosyncrasies of the training data. The authors’ transparency about this discrepancy is a model of scientific candor, and it underscores a broader point: computational psychiatry is still in the phase where careful validation matters more than headline accuracy figures.

Why does a Korean-language study matter so much? Most of the existing literature on linguistic markers in psychosis has been conducted in English, and it has been an open question whether the same features, reduced lexical diversity, simplified syntax, degraded coherence, would appear in a language with a very different structure. The findings support the cross-linguistic generalizability of these markers, suggesting that the linguistic footprint of cognitive impairment in schizophrenia is not an artifact of English grammar or English NLP tools. If the same computational signatures emerge in typologically distant languages, the case grows stronger that they reflect something fundamental about how disordered cognition shapes language, rather than something incidental to a particular language community.

The implications reach toward clinical practice. Cognitive impairment in schizophrenia is a powerful predictor of long-term functional outcomes, yet it is often not formally assessed, and there are no approved treatments that reliably reverse it. A speech-based screening tool, requiring nothing more than a few minutes of recorded conversation and automated analysis, could offer a low-cost, repeatable way to identify patients at risk, track cognitive change over time, and measure response to interventions in trials. The present study does not yet deliver such a tool, as the generalization gap in the machine learning results makes clear, but it establishes the essential groundwork: the features exist, they are measurable in Korean, they track cognitive status, and they can be extracted without subjective judgment. As speech corpora grow and models are validated across larger and more diverse cohorts, the conversation itself may become one of psychiatry’s most informative diagnostic instruments.

Subject of Research: Linguistic markers of cognitive impairment in schizophrenia identified through machine learning analysis of Korean speech

Article Title: Linguistic markers in schizophrenia patients with cognitive deficit: a machine learning study using Korean speech

Article References: Choi, S.-H., Li, L., Seo, J. H., Le, T.-H., Setiani, A., Odkhuu, S., Kim, W. S., Nazir, S., Piao, Y., & Chung, Y. C. (2026). Linguistic markers in schizophrenia patients with cognitive deficit: a machine learning study using Korean speech. Schizophrenia. https://doi.org/10.1038/s41537-026-00807-1

Image Credits: AI Generated

DOI: 10.1038/s41537-026-00807-1

Keywords: schizophrenia, cognitive impairment, natural language processing, machine learning, speech analysis, formal thought disorder, Korean language, linguistic markers, semantic coherence, biomarkers, psychiatry, cross-linguistic validity